Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.

Global market share of top pharma companies by anti-diabetic revenue 2017 and 2024

Published by
Matej Mikulic,
Jun 19, 2019
This statistic depicts the top ten pharmaceutical companies worldwide based on the global anti-diabetic revenue market share in 2017 and a projection for 2024. In 2017, Merck & Co accounted for some 12.8 percent of the global market for anti-diabetics, and is expected to decrease to some 5.3 percent in 2024. Anti-diabetic medication is commonly ingested orally, with the exception of insulin, exenatide, liraglutide, and pramlintide. Drugs used to treat diabetes mellitus are often called oral hypoglycemic agents or oral antihyperglycemic agents.

Top 10 pharmaceutical companies based on anti-diabetics market share worldwide in 2017 and 2024*

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

June 2018

Region

Worldwide

Survey time period

as of May 2018

Supplementary notes

Market share based on revenue
* Projected.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Monsanto-Bayer "

The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Monsanto-Bayer

Overview

4

Financials: Bayer

7

Financials: Monsanto

7

Competitors

8

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Novo NordiskGlobal pharmaceutical industryPharmaceutical industry in the U.S.DiabetesDiabetes in China
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu